Pre-made Tenatumomab benchmark antibody ( Whole mAb Radiolabelled, anti-TNC therapeutic antibody, Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-561

Pre-Made Tenatumomab biosimilar, Whole mAb Radiolabelled, Anti-TNC Antibody: Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Tenatumomab is a monoclonal antibody designed for the treatment of cancer.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-561-1mg 1mg Inquiry
GMP-Bios-ab-561-10mg 10mg Inquiry
GMP-Bios-ab-561-100mg 100mg Inquiry
GMP-Bios-ab-561-xmg ＞100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Tenatumomab biosimilar, Whole mAb Radiolabelled, Anti-TNC Antibody: Anti-150-225/DFNA56/GMEM/GP/HXB/JI/TN/TN-C therapeutic antibody
INN Name Tenatumomab
TargetTNC
FormatWhole mAb Radiolabelled
DerivationMouse
Species ReactivityHuman
CH1 IsotypeIgG2b
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2007
Year Recommended2008
Companiessigma-tau SpA
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedCancer
Development Techna